Filing Details
- Accession Number:
- 0001161697-24-000164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-28 16:45:34
- Reporting Period:
- 2024-03-27
- Accepted Time:
- 2024-03-28 16:45:34
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1369568 | Catalyst Pharmaceuticals Inc. | CPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1763511 | Brian Elsbernd | 355 Alhambra Circle Suite 801 Coral Gables FL 33134 | Chief Compliance/Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 Per Share | Disposition | 2024-03-27 | 25,000 | $16.44 | 124,433 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares were sold on the open market to fund payment of a personal tax liability and not as a result of any disagreement with the Company.
- Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $16.42 to $16.47 per share.